Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Post by JoeScotiaon Aug 01, 2020 8:50pm
256 Views
Post# 31354618

Why the U.S. still doesn’t have control of COVID-19, 6 month

Why the U.S. still doesn’t have control of COVID-19, 6 monthInterview on PBS on Jul 20 with The Rockefeller Foundation's President, Dr. Rajiv Shah and John Barry, professor at Tulane University's School of Public Health. This may have been mentioned before but this was the first time I was able to watch it. A few excerpts from the transcript. For some reason I can read Sona Nanotech between the lines.

Dr. Shah said "The good news is, there's some new technologies, particularly low-cost, less sensitive, but more frequent and rapid antigen tests that could change the reality in America. But we need to embrace that new opportunity now and act on it." and; 

"
And the government could make that possible by putting resources into advanced purchase contracts or using the Defense Production Act to make tens of millions of additional test kits available, especially these new low-cost rapid tests that get you a result in 15, 20 minutes."
<< Previous
Bullboard Posts
Next >>